A Forensics firm in Newcastle that has pioneered new techniques for crime scene investigation has acquired an Oxfordshire forensics services business.
Newcastle University-based ARRO Supranano, who have pioneered a new test that can give detailed information about a person from one fingerprint, have acquired Oxford-based Manlove Forensics Ltd in a strategic move.
ARRO Supranano employ seven at their INEX Centre base and will operate Manlove Forensics Ltd (MFL) as a separate firm.
The Wantage-based firm operates a purpose built laboratory facility where they provide analytical services used in investigation of road traffic accidents, drugs and CCTV and audio.
Eamonn Cooney, ARRO Group’s managing director, said: “MFL’s expert scientists and fully accredited laboratories engage in case reviews and crime scene attendance.
“Their analytical services include fingerprint / footwear, drugs, DNA, medicine, firearms / ballistics, ecology, collision investigation, digital and documents together with other chemistry and biology based examinations.
“The MFL acquisition provides ARRO with a strong UK platform with which to address the international forensics market estimated at $40 Billion.”
Speaking to The Journal following the close of the deal Eamonn Cooney said ARRO Supranano were also turning their attention to the US forensics market which is valued at some $17 million.
Arro Supranano was recently awarded the Forensic and Expert Witness Industry E-Mag Product Development Award for its groundbreaking Fingerprint technology.
Eamonn continued: ”Arro is also focusing on the major US forensics market where we have already established the SuprananoTM brand.
“For example the SuprananoTM fingerprinting products are sold in the USA through Forensic Source Inc and branded as Lightning Supranano powders and suspensions.”
ARRO has also just announced a formal collaborative R&D Alliance with the North Carolina based Genome ID Group LLC, The Centre for Advanced Forensic DNA AnalysisTM (CAFDA).
Eamonn described it as an important milestone in furthering ARRO’s fingerprinting/biomarker technology adn R&D within the USA.
Michael Heffernan, CEO, Genome ID Group, LLC, headquartered in Greenville, North Carolina, said: “ARRO Supranano’s fingerprint and biomarker technology is an innovative screening application and a complementary rapid solution to our DNA analysis using both standard and advanced whole genome array applications.”